An interview on why clinical trial diversity is important, and the need for including underserved and underrepresented communities in the development of new medicines.

Click or tap the video to watch more.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.